RNA5SP506

Across TCGA pan-cancer cohorts, RNA5SP506 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNA5SP506 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNA5SP506 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP506 expression acts as an unfavorable survival marker, although some lineages such as LUSC and COAD show a favorable association.

BLCA, ESCA, and MESO are the cancer types where RNA5SP506 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.063	0.688	<.001	72	view →
ESCA	DFS	Tertile	II,III,IV	0.349	0.589	<.001	55	view →
MESO	DFS	Tertile	II,III,IV	0.103	0.389	<.001	54	view →
UVM	OS	Tertile	All	0.255	0.612	.021	36	view →
LUSC	DFS	Tertile	All	0.917	0.366	.011	30	view →
ACC	DFS	Tertile	All	0.247	0.782	<.001	27	view →
COAD	OS	Tertile	All	0.885	0.588	.015	18	view →
UCEC	OS	Tertile	All	0.897	0.936	.010	16	view →
LIHC	DFS	Tertile	All	0.241	0.559	.019	9	view →
SARC	DFS	Tertile	All	0.157	0.635	.013	9	view →
PAAD	DFS	Tertile	All	1.000	0.478	.032	3	view →
SKCM	OS	Tertile	All	0.605	0.792	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNA5SP506–BLCA (OS)

Open the BLCA breakdown →